A61K 39/15
Reoviridae
Official title: Reoviridae, e.g. calf diarrhea virus
A61K39/15 (Reoviridae) appears on 174 US grants and 207 published applications in this corpus.
Search patents in A61K- Granted patents
- 174
- Published applications
- 207
- Assignees
- 147
- Inventors
- 489
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 3 | 0 |
| 1986 | 2 | 0 |
| 1987 | 4 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 3 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 5 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 5 | 0 |
| 2001 | 3 | 0 |
| 2002 | 1 | 6 |
| 2003 | 5 | 7 |
| 2004 | 2 | 7 |
| 2005 | 2 | 6 |
| 2006 | 2 | 1 |
| 2007 | 3 | 4 |
| 2008 | 3 | 11 |
| 2009 | 2 | 4 |
| 2010 | 4 | 12 |
| 2011 | 1 | 13 |
| 2012 | 7 | 8 |
| 2013 | 3 | 10 |
| 2014 | 7 | 7 |
| 2015 | 2 | 6 |
| 2016 | 9 | 9 |
| 2017 | 8 | 13 |
| 2018 | 9 | 12 |
| 2019 | 10 | 18 |
| 2020 | 16 | 9 |
| 2021 | 11 | 10 |
| 2022 | 7 | 11 |
| 2023 | 12 | 5 |
| 2024 | 6 | 9 |
| 2025 | 4 | 4 |
| 2026 | 2 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Attenuated avian reovirus strains 94826 C140 and 96139 C14014 Apr 2026US 12,599,659 B2University of Georgia Research Foundation, Inc.
- Adjuvant compositions13 Jan 2026US 12,521,433 B2Zoetis Services LLC
- Inactivated piscine orthoreovirus vaccine23 Dec 2025US 12,502,426 B2Intervet Inc.
- Rotavirus vaccines3 Jun 2025US 12,318,444 B2Cure Vac SE
- Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments18 Mar 2025US 12,251,440 B2Regeneron Pharmaceuticals, Inc.
- Muns fusion protein capable of forming microspheres and uses thereof27 Aug 2026US 2026/0248905 A1Universidade De Santiago De Compostela
- Vp4-based trivalent pseudovirus nanoparticle vaccine for rotavirus and methods of using same9 Jul 2026US 2026/0191949 A1Children's Hospital Medical Center
- Rotavirus b virus-like-particle compostions and antibody assays11 Jun 2026US 2026/0158131 A1University of Kentucky Research Foundation
- Cationic lipid based composition, formulation and use for nucleic acid vaccine delivery and preparation thereof19 Mar 2026US 2026/0077037 A1Bharat Biotech International Limited
- Rotavirus vaccines1 Jan 2026US 2026/0000749 A1CureVac AG
Most cited
By later US patents
- Preparation of inactivated viral vaccines92US 4,693,981 AAdvanced Genetics Research Institute · 1987
- Production of orthomyxoviruses in monkey kidney cells using protein-free media88US 6,146,873 ABaxter Aktiengesellschaft · 2000
- Preparation of inactivated viral vaccines49US 5,106,619 ADiamond Scientific Co. · 1992
- DNA vaccines against rotavirus infections47US 6,165,993 AUniversity of Massachusetts Medical Center · 2000
- DNA vaccines against rotavirus infections45US 5,620,896 AUniversity of Massachusetts Medical Center · 1997